DYN - Dyne Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DYN is currently covered by 11 analysts with an average price target of $35. This is a potential upside of $22.6 (95.53%) from yesterday's end of day stock price of $17.9.

Dyne Therapeutics 's activity chart (see below) currently has 120 price targets and 118 ratings on display. The stock rating distribution of DYN is 63.16% BUY and 36.84% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.23% with an average time for these price targets to be met of 214.61 days.

Highest price target for DYN is $60, Lowest price target is $10, average price target is $35.

Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 09-Sep-2026. First documented stock forecast 21-Feb-2017.

Currently out of the existing stock ratings of DYN, 12 are a BUY (63.16%), 7 are a HOLD (36.84%).

Split History since 2000:

5/25/10 1 for 5

8/22/00 2 for 1

2/1/00 69 for 100

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Mar-2025

$10

$-8.21 (-45.09%)

$16

7 days ago
(09-Sep-2026)

8/10 (80%)

$-9.19 (-47.89%)

120

Buy Since 26-Nov-2024

$30

$11.79 (64.74%)

$35

7 days ago
(09-Sep-2026)

2/9 (22.22%)

$10.81 (56.33%)

238

Buy Since 30-Apr-2024

$36

$17.79 (97.69%)

$45

7 days ago
(09-Sep-2026)

1/5 (20%)

$16.81 (87.60%)

72

Buy Since 13-Dec-2024

$26

$7.79 (42.78%)

$32

7 days ago
(09-Sep-2026)

0/3 (0%)

$6.81 (35.49%)

Buy Since 20-Jul-2022

$38

$17.06 (81.47%)

$38

6 months 7 days ago
(09-Mar-2026)

6/14 (42.86%)

$20.31 (114.81%)

197

Show more analysts

Please expand the browser size to see the chart

What is DYN (Dyne Therapeutics ) average time for price targets to be met?

On average it took 215 days for the stock forecasts to be reached, with an average price target met ratio of 36.23%.

Which analyst most recently updated their price target on DYN (Dyne Therapeutics )?

Tessa Romero

Which analyst has the most public recommendations on DYN (Dyne Therapeutics )?

Tessa Romero works at JPMORGAN and has 9 price targets and 6 ratings on DYN

Which analyst is the currently most bullish on DYN (Dyne Therapeutics )?

Andrew Fein with the highest potential upside of $41.79

Which analyst is the currently most reserved on DYN (Dyne Therapeutics )?

Michael Lapides with the lowest potential downside of -$8.68

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?